• About AMD

  • AMD Warning Signs

  • Treating AMD

  • Visudyne

  • Support for Low Vision

  • Caregiving

  • Common Questions

  • Helpful Resources

  • Need a Specialist?
    • Click to find one
  • Experiencing Vision Loss?
    • Test for AMD now!
  • Financial Assistance
    • Click for access
    • English
    • Spanish
    • English
    • Spanish

The full Prescribing Information for Visudyne includes a detailed list of ingredients as well as information on possible side effects, drug interactions, and precautions. It is provided in Portable Document Format (PDF). To view and print this document, you need a copy of the free Adobe® Reader®. If you already have Adobe® Reader® installed, click "View full Prescribing Information."

If you need Adobe® Reader®, click here to download the free reader.

Adobe, the Adobe logo, and Reader are registered trademarks of Adobe Systems Incorporated in the United States and/or other countries.

View full Prescribing Information.

Is Visudyne for me?

Visudyne is a treatment to help slow the loss of vision in persons with predominantly classic wet AMD.

Important Safety Information

Visudyne therapy is not for everyone. People who have an abnormal sensitivity to light (a condition called porphyria) and those with allergies to any of the ingredients should not receive Visudyne. (Your doctor has a list of ingredients in Visudyne.) Check with your doctor or healthcare professional to see if you might be allergic to any component of Visudyne therapy. Only your doctor can determine if Visudyne is right for you.

Between 1% and 5% of patients experienced a substantial decrease in vision in the first 7 days after treatment, though some patients achieved partial recovery. Patients who experience substantial vision loss should consult their ophthalmologist or retinal specialist immediately. The most commonly reported adverse events (10-30%) were injection site reactions, temporary back pain during injection, changes in vision, including blurring, decreased sharpness in vision, and gaps in vision.

Patients should avoid direct sunlight or bright indoor light for 5 days following therapy with Visudyne.

Patients who have to go outdoors in daylight after treatment must protect all parts of their skin and eyes by wearing protective clothing and dark glasses. Ultraviolet (UV) sunscreens are not effective in protecting against photosensitivity reactions.